Theralizumab

Tax included
Theralizumab (TGN1412) is a superagonist anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can be used for the research of rheumatoid arthritis.
MedChemExpress 
HY-P9975

Data sheet

Size
Multiple sizes
Reactivity
CD28
Application
COVID-19-immunoregulation
CAS
906068-56-2